These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 13431542)

  • 21. [Non-A non-B hepatitis caused by transfusing American antihemophilic globulin (factor VIII) in patients with hemophilia].
    Zhang Z; Li YH; Li XF
    Zhonghua Nei Ke Za Zhi; 1988 Feb; 27(2):82-4, 134. PubMed ID: 3141119
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapy of hemophilia A with a cryoprecipitated antihemophilic factor].
    Ollendorff P
    Ugeskr Laeger; 1969 May; 131(20):877-81. PubMed ID: 5795169
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biological half-time of factor VIII antigen (antihemophilic globulin) in hemophilia A and in von Willebrand's disease].
    Uszyński L
    Acta Haematol Pol; 1974; 5(3):189-94. PubMed ID: 4546992
    [No Abstract]   [Full Text] [Related]  

  • 24. [Quantitative determination of antihemophilic globulin (Factor VIII)].
    Lisichkov T
    Vutr Boles; 1972; 11(4):62-7. PubMed ID: 4680004
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the response of patients with classic hemophilia to transfusion with concentrates of antihemophilic factor. A difference in the half-life of antihemophilic factor as measured by procoagulant and immunologic techniques.
    Bennett B; Ratnoff OD
    J Clin Invest; 1972 Oct; 51(10):2593-6. PubMed ID: 4626847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on a circulating anticoagulant against antihemophilic factor in patients with hemophilia A].
    van Creveld S; Mochtar IA; Charante-Meulen CC
    Ned Tijdschr Geneeskd; 1967 Sep; 111(37):1589-93. PubMed ID: 5602751
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on the purification of antihemophilic factor (factor VIII). II. Separation of partially purified antihemophilic factor by gel filtration of plasma.
    Ratnoff OD; Kass L; Lang PD
    J Clin Invest; 1969 May; 48(5):957-62. PubMed ID: 5780204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preparation of antihemophilic kryoprecipitates (AHKP) from fresh plasma and its use in hemophilia A].
    Brüster H
    Monatsschr Kinderheilkd (1902); 1968 Jun; 116(6):388-90. PubMed ID: 5718328
    [No Abstract]   [Full Text] [Related]  

  • 29. [APROPOS OF THE PREPARATION OF ANTIHEMOPHILIC PLASMA].
    KUCHUK AP; SHIMANSKAIA BM
    Probl Gematol Pereliv Krovi; 1965 May; 10():43-5. PubMed ID: 14310564
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on human factor VIII (antihemophilic factor). I. Purification and properties of factor VIII (author's transl)].
    Niiya K
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):534-42. PubMed ID: 308760
    [No Abstract]   [Full Text] [Related]  

  • 31. A new high-potency glycine-precipitated antihemophilic factor (AHF) concentrate. Treatment of classical hemophilia and hemophilia with inhibitors.
    Brinkhous KM; Shanbrom E; Roberts HR; Webster WP; Fekete L; Wagner RH
    JAMA; 1968 Aug; 205(9):613-7. PubMed ID: 5695099
    [No Abstract]   [Full Text] [Related]  

  • 32. [Concentrated antihemophilic globulin in the treatment of hemorrhagic syndromes].
    Baklaja F; Cvetković V; Stajić M; Krivokapić L
    Bilt Hematol Transfuz; 1976; 4(3):61-6. PubMed ID: 1008799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspects of the management of hemophilia in childhood. Availability of newer concentrates of antihemophilic factor failitates management.
    Strauss HS
    R I Med J; 1966 Aug; 49(8):466-8. PubMed ID: 5222119
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antihemophilic cryoprecipitate from fresh plasma and its use in hemophilia A].
    Brüster H; Glassner K; Riech PC
    Dtsch Med Wochenschr; 1967 Oct; 92(41):1859-66. PubMed ID: 6057144
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acquired female pseudohemophilia due to the presence of an antihemophilic factor A inhibitor].
    MASURE R
    Rev Belg Pathol Med Exp; 1955 Jan; 24(1):23-37. PubMed ID: 14385368
    [No Abstract]   [Full Text] [Related]  

  • 36. Coincident classic hemophilia and "idiopathic" thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII).
    Ratnoff OD; Menitove JE; Aster RH; Lederman MM
    N Engl J Med; 1983 Feb; 308(8):439-42. PubMed ID: 6401839
    [No Abstract]   [Full Text] [Related]  

  • 37. The history of hemophilia.
    Franchini M; Mannucci PM
    Semin Thromb Hemost; 2014 Jul; 40(5):571-6. PubMed ID: 24911674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. USE OF ANTIHEMOPHILIC FACTOR (PLASMA FRACTION I-O) DURING CORRECTION OF KNEE-JOINT DEFORMITIES IN HEMOPHILIA A. REPORT OF THREE CASES INCLUDING ONE OSTEOTOMY.
    AHLBERG A; NILSSON IM; BAUER GC
    J Bone Joint Surg Am; 1965 Mar; 47():323-32. PubMed ID: 14261808
    [No Abstract]   [Full Text] [Related]  

  • 39. [Does lyophilization cause the appearance of a non-specific thromboplastic activity in the blood? Study of the antihemophilic factors A and B].
    DUCOS J; BIERME R
    C R Seances Soc Biol Fil; 1960; 154():808-12. PubMed ID: 13724735
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of recombinant antihemophilic factor in the treatment of two patients with classic hemophilia.
    White GC; McMillan CW; Kingdon HS; Shoemaker CB
    N Engl J Med; 1989 Jan; 320(3):166-70. PubMed ID: 2492083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.